欢迎访问《中国临床药理学与治疗学》杂志官方网站,今天是 分享到:

中国临床药理学与治疗学 ›› 2011, Vol. 16 ›› Issue (4): 423-426.

• 药物治疗学 • 上一篇    下一篇

舒必利与奥氮平治疗神经性厌食症患者的对照研究

钟智勇1,2, 吴小立1, 程敏锋1, 张晋碚1   

  1. 1中山大学附属第三医院精神科,广州 510630,广东;
    2中南大学湘雅二医院精神卫生中心,长沙 410011,湖南
  • 收稿日期:2011-04-11 修回日期:2011-04-24 发布日期:2011-06-22
  • 通讯作者: 张晋碚,男,主任医师,研究方向:老年精神医学。E-mail: 89.534.72@163.com
  • 作者简介:钟智勇,主治医师,在读博士研究生,研究方向:焦虑障碍的功能影像学。Tel: 13543469476 E-mail: zhongpsydoc@163.com

Control study of Sulpiride and Olanzapine in the treatment of anorexia nervosa

ZHONG Zhi-yong1,2,WU Xiao-li1 ,CHEN Min-feng1,ZHANG Jin-bei1   

  1. 1Department of Psychiatry, the Third Affiliated Hospital of Sun Yet-sen University,Guangzhou 510630,Guangdong,China;
    2Mental Health Center, the Second Xiangya Hospital of Central South University,Changsha 410011,Hunan,China
  • Received:2011-04-11 Revised:2011-04-24 Published:2011-06-22

摘要: 目的: 比较舒必利联合帕罗西汀与奥氮平联合帕罗西汀治疗神经性厌食症的疗效与副反应差别。 方法: 分析57例(其中使用舒必利组25例,奥氮平组32例)住院神经性厌食症患者治疗8周前后的体重,体重指数,汉密尔顿焦虑量表(HAMA),汉密尔顿抑郁量表(HAMD)及副反应量表(TESS)的结果。 结果: 两组治疗8周后体重,体重指数及汉密尔顿焦虑量表、汉密尔顿抑郁量表总分均比入院时有明显改善。同时治疗8周后奥氮平组比舒必利组在改善体重及体重指数上要更加明显,两组间比较有统计学差异,而在HAMA、HAMD、TESS的比较上未见统计学差异。 结论: 舒必利联合帕罗西汀与奥氮平联合帕罗西汀均能有效改善神经性厌食症患者的临床症状,奥氮平联合帕罗西汀相对舒必利联合帕罗西汀而言改善体重及体重指数的效果更佳,两组在副反应上未见明显差异。

关键词: 神经性厌食症, 舒必利, 奥氮平, 体重指数

Abstract: AIM: To compare the difference of effect and side effects of Sulpiride with Paroxetine and Olanzapine with Paroxetine in the treatment of anorexia nervosa. METHODS: 57 anorexia vervosa patients were involved in the research, including 25 cases of Sulpiride group,32 cases of Olanzapine group, before and after the treatment, body weight, body mass index (BMI), Hamilton anxiety scale (HAMA), Hamilton depression rating scale (HAMD) and Treatment emergent side-effect scale (TESS) were used to evaluate the curative effect and the adverse drug reactions. RESULTS: After 8 weeks treatment ,the indexes of body weight, BMI, HAMA,HAMD were obviously better than those of before treatment (P<0.05). The indexes of body weight and BMI of Olanzapine group were better than those in Sulpiride group after 8 weeks treatment (P<0.05), but there were no difference of HAMA,HAMD and TESS between two groups(P>0.05) . CONCLUSION: After analysis of the indexes as body weight, BMI, HAMA, HAMD and TESS, the following conclusions are made: the two methods are both effective to the treatment of anorexia noversa, but the Olanzapine with Paroxetine is better than Sulpiride with Paroxetine in improving the body weight and the BMI. The difference of the adverse drug reactions is not found in the two groups.

Key words: Anorexia nervosa, Sulpiride, Olanzapine, Body mass index(BMI)

中图分类号: